ATP Synthase, an Emerging Target in TB Drug Discovery: Review of SAR and Clinical Pharmacology of Diarylquinoline Inhibitors.
Curr Drug Targets
; 22(11): 1207-1221, 2021.
Article
in En
| MEDLINE
| ID: mdl-33480344
Key words
Full text:
1
Collection:
01-internacional
Database:
MEDLINE
Main subject:
Tuberculosis
/
ATP Synthetase Complexes
/
Drug Discovery
/
Diarylquinolines
/
Antitubercular Agents
Limits:
Humans
Language:
En
Journal:
Curr Drug Targets
Journal subject:
TERAPIA POR MEDICAMENTOS
Year:
2021
Document type:
Article
Affiliation country:
India
Country of publication:
United Arab Emirates